Roepman Paul
Agendia BV, Science Park 406, 1098 XH Amsterdam, The Netherlands.
Bioanalysis. 2010 Feb;2(2):249-62. doi: 10.4155/bio.09.172.
During the last two decades, an increasing number of microarray studies have identified gene-expression profiles that link disease characteristics to patient outcome. However, despite improvements in technology and the clinical relevance of the identified profiles, only a handful of microarray tests are currently available for clinical use. So why have microarrays, regardless of the great application and success within a research setting, not yet been embraced for routine diagnostic use? Besides the strengths of microarray diagnostics, this perspective will outline the important challenges that need to be considered for successful translation of a gene profile into a routine diagnostic test. Finally, some new microarray technologies will be reviewed and an outlook for the future of diagnostic microarrays will be presented.
在过去二十年中,越来越多的微阵列研究确定了将疾病特征与患者预后联系起来的基因表达谱。然而,尽管技术有所改进且所确定的谱具有临床相关性,但目前仅有少数微阵列检测可用于临床。那么,为何微阵列尽管在研究环境中有巨大的应用价值和成功案例,却尚未被用于常规诊断呢?除了微阵列诊断的优势外,本观点将概述将基因谱成功转化为常规诊断检测需要考虑的重要挑战。最后,将回顾一些新的微阵列技术,并展望诊断微阵列的未来。